featured
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Patients With Subclinical Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
J Am Coll Cardiol 2024 Jul 23;84(4)354-364, RD Lopes, CB Granger, DM Wojdyla, WF McIntyre, M Alings, T Mani, C Ramasundarahettige, L Rivard, D Atar, DH Birnie, G Boriani, G Amit, P Leong-Sit, C Rinne, GZ Duray, MR Gold, SH Hohnloser, V Kutyifa, J Benezet-Mazuecos, J Cosedis Nielsen, C Sticherling, AP Benz, C Linde, J Kautzner, P Mabo, GH Mairesse, SJ Connolly, JS HealeyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.